Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Ovulation
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
==Ovulation suppression== [[Combined hormonal contraceptive]]s inhibit [[follicular phase|follicular development]] and prevent ovulation as a primary mechanism of action.<ref name="Nelson 2011">{{cite book| last1 = Nelson| first1 = Anita L.| last2 = Cwiak| first2 = Carrie| editor1-last = Hatcher| editor1-first = Robert A.| editor2-last = Trussell| editor2-first = James| editor3-last = Nelson| editor3-first = Anita L.| editor4-last = Cates| editor4-first = Willard | editor5-last = Kowal| editor5-first = Deborah| editor6-last = Policar| editor6-first = Michael S. | name-list-style = vanc | title = Contraceptive technology| edition = 20th revised| year = 2011| publisher = Ardent Media| location = New York| isbn = 978-1-59708-004-0| oclc = 781956734| pages = 249–341| chapter = Combined oral contraceptives (COCs)| issn = 0091-9721 }} pp. 257–258</ref> The ''ovulation-inhibiting dose'' (OID) of an [[estrogen (medication)|estrogen]] or [[progestogen]] refers to the dose required to consistently inhibit ovulation in women.<ref name="pmid22078182">{{cite journal | vauthors = Endrikat J, Gerlinger C, Richard S, Rosenbaum P, Düsterberg B | title = Ovulation inhibition doses of progestins: a systematic review of the available literature and of marketed preparations worldwide | journal = Contraception | volume = 84 | issue = 6 | pages = 549–57 | date = December 2011 | pmid = 22078182 | doi = 10.1016/j.contraception.2011.04.009 }}</ref> Ovulation inhibition is an [[antigonadotropic]] effect and is mediated by inhibition of the secretion of the [[gonadotropin]]s, LH and FSH, from the pituitary gland. In [[assisted reproductive technology]] including [[in vitro fertilization]], cycles where a [[transvaginal oocyte retrieval]] is planned generally necessitates ovulation suppression, because it is not practically feasible to collect oocytes after ovulation. For this purpose, ovulation can be suppressed by either a [[GnRH agonist]] or a [[GnRH antagonist]], with different protocols depending on which substance is used. {{further|Suppression of spontaneous ovulation in ovarian hyperstimulation}}
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)